- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Bausch & Lomb forms retina team
San Dimas, CA-A new team of representatives will provide sales support to surgeons in the United States using Bausch & Lomb retina products, the company has announced.
San Dimas, CA-A new team of representatives will provide sales support to surgeons in the United States using Bausch & Lomb retina products, the company has announced.
The group will provide support for a microincision cataract surgery system (Millennium) and associated products, a brand of vitreoretinal instruments (Storz), two sustained drug-delivery implants (Retisert and Vitrasert), and an eye vitamin and mineral supplement (PreserVision). Vitreoretinal specialists will provide additional technical and clinical expertise to users of the company’s vitreoretinal products.
Edward Kennedy, a 14-year employee of the company, has been appointed director of retina to lead the new team.
Bausch & Lomb Surgical is based in San Dimas, CA.
